Literature DB >> 27767035

Therapy: Targeted delivery of thyroid hormone improves metabolic outcomes.

Claire Greenhill.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27767035     DOI: 10.1038/nrendo.2016.176

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

Authors:  Brian Finan; Christoffer Clemmensen; Zhimeng Zhu; Kerstin Stemmer; Karine Gauthier; Luisa Müller; Meri De Angelis; Kristin Moreth; Frauke Neff; Diego Perez-Tilve; Katrin Fischer; Dominik Lutter; Miguel A Sánchez-Garrido; Peng Liu; Jan Tuckermann; Mohsen Malehmir; Marc E Healy; Achim Weber; Mathias Heikenwalder; Martin Jastroch; Maximilian Kleinert; Sigrid Jall; Sara Brandt; Frédéric Flamant; Karl-Werner Schramm; Heike Biebermann; Yvonne Döring; Christian Weber; Kirk M Habegger; Michaela Keuper; Vasily Gelfanov; Fa Liu; Josef Köhrle; Jan Rozman; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Susanna M Hofmann; Bin Yang; Matthias H Tschöp; Richard DiMarchi; Timo D Müller
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.